Literature DB >> 15239952

Sef is a spatial regulator for Ras/MAP kinase signaling.

Satoru Torii1, Morioh Kusakabe, Takuya Yamamoto, Momoko Maekawa, Eisuke Nishida.   

Abstract

Spatiotemporal control of the Ras/ERK MAP kinase signaling pathway is among the key mechanisms for regulating a wide variety of cellular processes. In this study, we report that human Sef (hSef), a recently identified inhibitor whose action mechanism has not been fully defined, acts as a molecular switch for ERK signaling by specifically blocking ERK nuclear translocation without inhibiting its activity in the cytoplasm. Thus, hSef binds to activated forms of MEK, inhibits the dissociation of the MEK-ERK complex, and blocks nuclear translocation of activated ERK. Consequently, hSef inhibits phosphorylation and activation of the nuclear ERK substrate Elk-1, while it does not affect phosphorylation of the cytoplasmic ERK substrate RSK2. Downregulation of endogenous hSef by hSef siRNA enhances the stimulus-induced ERK nuclear translocation and the activity of Elk-1. These results thus demonstrate that hSef acts as a spatial regulator for ERK signaling by targeting ERK to the cytoplasm.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15239952     DOI: 10.1016/j.devcel.2004.05.019

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  103 in total

Review 1.  GnRH signaling, the gonadotrope and endocrine control of fertility.

Authors:  Stuart P Bliss; Amy M Navratil; Jianjun Xie; Mark S Roberson
Journal:  Front Neuroendocrinol       Date:  2010-05-06       Impact factor: 8.606

Review 2.  Control of MAP kinase signaling to the nucleus.

Authors:  Kunio Kondoh; Satoru Torii; Eisuke Nishida
Journal:  Chromosoma       Date:  2005-05-18       Impact factor: 4.316

Review 3.  Comparative mechanisms of branching morphogenesis in diverse systems.

Authors:  Pengfei Lu; Mark D Sternlicht; Zena Werb
Journal:  J Mammary Gland Biol Neoplasia       Date:  2006-10       Impact factor: 2.673

4.  Characterization of a novel low-molecular-mass dual specificity phosphatase-4 (LDP-4) expressed in brain.

Authors:  Kentaro Takagaki; Hiroshi Shima; Nobuhiro Tanuma; Miyuki Nomura; Takeshi Satoh; Masahiko Watanabe; Kunimi Kikuchi
Journal:  Mol Cell Biochem       Date:  2006-09-26       Impact factor: 3.396

5.  Mouse tissues that undergo neoplastic progression after K-Ras activation are distinguished by nuclear translocation of phospho-Erk1/2 and robust tumor suppressor responses.

Authors:  Neha Parikh; Ryan L Shuck; Thuy-Ai Nguyen; Alan Herron; Lawrence A Donehower
Journal:  Mol Cancer Res       Date:  2012-04-24       Impact factor: 5.852

Review 6.  Cellular signaling by fibroblast growth factors (FGFs) and their receptors (FGFRs) in male reproduction.

Authors:  Leanne M Cotton; Moira K O'Bryan; Barry T Hinton
Journal:  Endocr Rev       Date:  2008-01-23       Impact factor: 19.871

7.  Pseudophosphatase STYX modulates cell-fate decisions and cell migration by spatiotemporal regulation of ERK1/2.

Authors:  Veronika Reiterer; Dirk Fey; Walter Kolch; Boris N Kholodenko; Hesso Farhan
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-11       Impact factor: 11.205

8.  Deficiency of Sef is associated with increased postnatal cortical bone mass by regulating Runx2 activity.

Authors:  Qing He; Xuehui Yang; Yan Gong; Dmitry Kovalenko; Ernesto Canalis; Clifford J Rosen; Robert E Friesel
Journal:  J Bone Miner Res       Date:  2014       Impact factor: 6.741

9.  Interaction with Shc prevents aberrant Erk activation in the absence of extracellular stimuli.

Authors:  Kin Man Suen; Chi-Chuan Lin; Roger George; Fernando A Melo; Eleanor R Biggs; Zamal Ahmed; Melanie N Drake; Swathi Arur; Stefan T Arold; John E Ladbury
Journal:  Nat Struct Mol Biol       Date:  2013-04-14       Impact factor: 15.369

10.  Sef Regulates Epithelial-Mesenchymal Transition in Breast Cancer Cells.

Authors:  Qing He; Yan Gong; Lindsey Gower; Xuehui Yang; Robert E Friesel
Journal:  J Cell Biochem       Date:  2016-03-16       Impact factor: 4.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.